Kaur, Primal
Chow, Vincent
Zhang, Nan
Moxness, Michael
Kaliyaperumal, Arunan
Markus, Richard
Funding for this research was provided by:
Amgen
This article is maintained by: Elsevier
Article Title: A randomised, single-blind, single-dose, three-arm, parallel-group study in healthy subjects to demonstrate pharmacokinetic equivalence of ABP 501 and adalimumab
Journal Title: Annals of the Rheumatic Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1136/annrheumdis-2015-208914
Content Type: article
Copyright: Copyright © 2016 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.